Q6N089 (Q6N089_HUMAN) Homo sapiens (Human)

Ig-like domain-containing protein UniProtKBInterProInteractive Modelling

472 aa; Sequence (Fasta)

Available Structures

18 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin… Heteromer
I0AXC3; Q8TCD0;
20-245
72.85NAG;NAG;NAG;NAG;NAG;NAG;ZN;
VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure Heteromer
P0DOX5; Q2N0S6; Q2N0S7; Q6P5S8; Q8N5F4;
20-245
51.9227×NAG;NAG;NAG;NAG; 21×NAG;
Crystal structure of Fab fragment of anti-CD22 Epratuzumab Heteromer
Q8TCD0;
21-245
47.96
RSV prefusion F bound to RSD5 Fab Heteromer
P03420; Q8N355;
20-244
88.013×SO4;NAG;
Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated … Heteromer
P01834;
20-243
75.0
Crystal structure of HIV-1 broadly neutralizing antibody PGT152 Heteromer
Q8TCD0;
20-243
83.33
Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (14:0) Heteromer
P01834;
20-243
44.44NKN;
Crystal structure of the humanized apo LT3015 anti-lysophosphatidic acid antibody Fab fragment Heteromer
P01834;
20-243
44.44SO4;PGE;
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment Heteromer
Q8TCD0;
20-243
48.45SO4;EDO;CL;
Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (18:2) Heteromer
P01834;
20-243
44.4418L;
Crystal structure of catalytic elimination antibody 34E4, orthorhombic crystal form Heteromer
Q8TCD0;
20-243
63.46GOL;SO4;
Crystal structure of catalytic elimination antibody 34E4, triclinic crystal form Heteromer
Q8TCD0;
20-243
63.46CD;
Crystal structure analysis of Fab 2G12 in complex with peptide 2G12.1 Heteromer
20-243
75.0
Human antibody H2897 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 Heteromer
A7UPX0; Q6PIL8;
20-242
88.46NAG;NAG; 15×NAG;
MACV GP1 CR1-07 Fab complex Heteromer
Q0KKI6; Q8AZ57;
21-243
69.61NAG;
Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide Heteromer
G9HS63; Q8N5F4;
21-242
87.5GOL;
Crystal structure of human monoclonal antibody H3v-47 Heteromer
Q8TCD0;
20-241
72.22
Crystal Structure of the Broadly Neutralizing Anti-HIV Fab F105 Heteromer
Q6PIL8;
21-242
51.06